Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)
Clinical trial NCT01451437 · TERMINATED
Trial details
- NCT number
- NCT01451437
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-18
- Primary completion
- 2014-09-05
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.